ConductScience.org, home

Paper37697173

Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-1: the Effects of Metal Ions and Buffers.

Jakaria SM and 2 others. Pharm Res, 2023. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-1: the Effects of Metal Ions and Buffers. Papers, record 37697173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37697173

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-1: the Effects of Metal Ions and Buffers.
PubMed
Journal
Pharm Res
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2026-10-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jakaria SMSardar Mhttps://orcid.org/0000-0002-8887-230X
2Budil DEDavid Ehttps://orcid.org/0000-0003-2384-7928
3Murtagh JJames

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MetalsMajor topic
WaterMajor topic
Buffers
Citrates
Citric Acid
Acetates
Hydrogen-Ion Concentration
Solutions
Teicoplanin

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118983853Vancomycin forms ligand-mediated supramolecular complexes.J Mol Biol2009https://conductscience.org/library/papers/18983853PubMed
29062068Interaction of oxytocin with Ca2+: II. Proton magnetic resonance and molecular modeling studies of conformations of the hormone and its Ca2+ complex.Biopolymers1996https://conductscience.org/library/papers/9062068PubMed
327354809Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI).Ther Clin Risk Manag2016https://conductscience.org/library/papers/27354809PubMed
437118348Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions.Pharm Res2023https://conductscience.org/library/papers/37118348PubMed
526078847Stereocontrolled 1,2-cis glycosylation as the driving force of progress in synthetic carbohydrate chemistry.Chem Sci2015https://conductscience.org/library/papers/26078847PubMed
636530576Glycopeptide antibiotic drug stability in aqueous solution.AAPS Open2022https://conductscience.org/library/papers/36530576PubMed
733473156Dalbavancin: novel candidate for COVID-19 treatment.Cell Res2021https://conductscience.org/library/papers/33473156PubMed
817083861Dalbavancin: a review for dermatologists.Dermatol Online J2006https://conductscience.org/library/papers/17083861PubMed
924608916Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin.Org Biomol Chem2014https://conductscience.org/library/papers/24608916PubMed
1034204961Emerging Treatment Options for Multi-Drug-Resistant Bacterial Infections.Life (Basel)2021https://conductscience.org/library/papers/34204961PubMed
1129363950Developments in Glycopeptide Antibiotics.ACS Infect Dis2018https://conductscience.org/library/papers/29363950PubMed
1220143256Stability of protein pharmaceuticals: an update.Pharm Res2010https://conductscience.org/library/papers/20143256PubMed
1335065769Antimicrobial resistance: time to repurpose the Global Fund.Lancet2022https://conductscience.org/library/papers/35065769PubMed
1415713062Oxytocin-receptor binding: why divalent metals are essential.J Am Chem Soc2005https://conductscience.org/library/papers/15713062PubMed
1514631936
International Conference on Harmonisation; Stability Data Package for Registration Applications in Climatic Zones III and IV; Stability Testing of New Drug Substances and Products; availability. Notice.
Fed Regist2003https://conductscience.org/library/papers/14631936PubMed
1626942013Multidrug Resistant and Extensively Drug Resistant Bacteria: A Study.J Pathog2016https://conductscience.org/library/papers/26942013PubMed
1717964744Stabilization of a polypeptide in non-aqueous solvents.Int J Pharm2008https://conductscience.org/library/papers/17964744PubMed
1825798039Medication-induced hypokalemia.P T2015https://conductscience.org/library/papers/25798039PubMed
199876591Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug Substances and Products to countries of climatic zones III and IV.Drug Dev Ind Pharm1998https://conductscience.org/library/papers/9876591PubMed
2021448747A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.AAPS J2011https://conductscience.org/library/papers/21448747PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
39771484Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-2: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Acetate Buffer with and Without Divalent Metal Ions.Pharmaceutics2024https://conductscience.org/library/papers/39771484

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37697173

GET https://conductscience.org/api/papers/v1/37697173/authors